J. Whitaker
Chief Tech/Sci/R&D Officer en OMEROS CORPORATION .
Perfil
J.
Steven Whitaker is currently the Vice President-Clinical Development at Omeros Corp.
He previously worked as the Divisional Vice President at ICOS Corp from 1994 to 2007 and as the Chief Medical Officer & VP-Clinical Development at Allon Therapeutics, Inc. from 2008 to 2010.
Whitaker holds a graduate degree from the University of Washington, an undergraduate degree from Butler University, and a doctorate degree from The Indiana University School of Medicine.
Cargos activos de J. Whitaker
| Empresas | Cargo | Inicio |
|---|---|---|
| OMEROS CORPORATION | Chief Tech/Sci/R&D Officer | 01/11/2019 |
Antiguos cargos conocidos de J. Whitaker.
| Empresas | Cargo | Fin |
|---|---|---|
| ALLON THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/03/2010 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | 01/05/2007 |
Formación de J. Whitaker.
| University of Washington | Graduate Degree |
| Butler University | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| ALLON THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
- Bolsa de valores
- Insiders
- J. Whitaker
